Literature DB >> 10070855

'Should a mammographic screening programme carry the warning: screening can damage your health!'?

H Thornton, M Baum.   

Abstract

The balanced presentation afforded by convening a Citizens' Jury when considering a major question such as the introduction of a breast screening programme is advocated. This method would enable account to be taken of all the costs, both human and financial, to all those affected, both participating and organizing, as well as the benefits. Provision of such a democratic opportunity enables consideration to be given to a broad range of factors, by selection of an appropriate range of witnesses, with the advantage of involving the lay public in this decision-making process. Attendance by health correspondents, medical journalists and other media representatives enables publicization of a democracy in action whilst helping to inform the wider debate. Such an exercise could inform whether the NHS BSP should continue in its current form.

Entities:  

Mesh:

Year:  1999        PMID: 10070855      PMCID: PMC2362645          DOI: 10.1038/sj.bjc.6690111

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  4 in total

1.  Should asymptomatic haemochromatosis be treated? Alternative strategies to appropriate diagnosis need testing.

Authors:  J Emery; P Rose
Journal:  BMJ       Date:  2000-10-14

2.  Informed consent for mammography screening: modelling the risks and benefits for American women.

Authors:  Tom Marshall
Journal:  Health Expect       Date:  2005-12       Impact factor: 3.377

3.  Information and involvement.

Authors:  H Thornton
Journal:  Health Expect       Date:  2001-03       Impact factor: 3.377

4.  How a deliberative approach includes women in the decisions of screening mammography: a citizens' jury feasibility study in Andalusia, Spain.

Authors:  José M Baena-Cañada; Violeta Luque-Ribelles; Alicia Quílez-Cutillas; Petra Rosado-Varela; Encarnación Benítez-Rodríguez; Soledad Márquez-Calderón; Juan Manuel Rivera-Bautista
Journal:  BMJ Open       Date:  2018-05-05       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.